FFCP PHASE1:Hg19::chr4:81952607..81952617,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=651 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |||
|HGNC=1070 | |||
|TSSclassifier=strong | |||
|UniProt=P12645 | |||
|association_with_transcript=439bp_to_BC096269,BC096270,BC096271,BC117514_5end | |||
|coexpression_cluster_id=C62 | |||
|description=CAGE_peak_7_at_BMP3_5end | |||
|id=chr4:81952607..81952617,+ | |||
|ontology_enrichment_celltype=CL:0000945!2.40e-13!24;CL:0000826!2.40e-13!24;CL:0000819!7.40e-11!1;CL:0000542!9.14e-08!53;CL:0000051!9.14e-08!53 | |||
|ontology_enrichment_celltype_v019=CL:0000785;2.55e-98;1!CL:0000819;2.55e-98;1!CL:0000945;1.03e-17;24!CL:0000542;3.95e-11;53!CL:0000236;5.70e-09;13 | |||
|ontology_enrichment_celltype_v019_2=CL:0000819,2.55e-98,1;CL:0000785,4.52e-50,2;CL:0000955,4.52e-50,2;CL:0000818,4.52e-50,2;CL:0000954,4.52e-50,2;CL:0000816,4.52e-50,2;CL:0000817,5.96e-34,3;CL:0000945,1.03e-17,24;CL:0000826,1.03e-17,24;CL:0000838,6.99e-09,52;CL:0000542,9.74e-09,53;CL:0000051,9.74e-09,53;CL:0000236,2.00e-08,14 | |||
|ontology_enrichment_development_v019=CL:0000954;4.52e-50;2!CL:0000051;3.95e-11;53 | |||
|ontology_enrichment_disease=DOID:0060073!7.40e-11!1;DOID:8675!7.40e-11!1;DOID:0050619!8.95e-11!1;DOID:1357!8.95e-11!1;DOID:12603!1.19e-10!1;DOID:3151!1.30e-10!1;DOID:3149!1.30e-10!1 | |||
|ontology_enrichment_disease_v019=DOID:0060073;2.55e-98;1!DOID:8675;2.55e-98;1!DOID:0060058;2.00e-40;10!DOID:2531;8.57e-09;51!DOID:0060083;8.57e-09;51 | |||
|ontology_enrichment_disease_v019_2=DOID:0060073,2.55e-98,1;DOID:8675,2.55e-98,1;DOID:0060058,2.00e-40,10;DOID:2531,4.95e-09,51;DOID:0060083,4.95e-09,51 | |||
|ontology_enrichment_uberon=UBERON:0001764!8.95e-11!1;UBERON:0001825!8.95e-11!1;UBERON:0002171!1.08e-10!1;UBERON:0006518!1.08e-10!1;UBERON:0008949!1.08e-10!1;UBERON:0000101!1.08e-10!1;UBERON:0002167!1.08e-10!1;UBERON:0002372!3.96e-10!1;UBERON:0001961!3.96e-10!1;UBERON:0001744!3.96e-10!1;UBERON:0001735!3.96e-10!1;UBERON:0002581!4.33e-10!1;UBERON:0001872!6.47e-08!5 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.152826811495903,0.164201178899891,0.157421562627358,0,0,0,0,0,0,4.7254992353984,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.546138611262131,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.207322110030741,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.371606350251437,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.254253650292766,0,0,0,0,0,0,0,0,0,0.219385397153973,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.55436704901932,0,0,0,0,0.30607276163049,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.335434687599266,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.414239055347196,0,0,0,0,0,0,0,0,0.628216385000937,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0634158101939068,0,0,0,0,0.255524855279191,0,0,0,0,0,0,0,0.135939465953663,0.0657727735628491,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.22589216407792,0,0,0.154348316215889,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.730336388246517,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0673520530145875,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p7@BMP3 | |||
}} |
Revision as of 01:53, 22 January 2014
Short description: | p7@BMP3 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_7_at_BMP3_5end |
Coexpression cluster: | C62_Burkitt_tonsil_CD19_submaxillary_spleen_salivary_lymph |
Association with transcript: | 439bp_to_BC096269, BC096270, BC096271, BC117514_5end |
EntrezGene: | BMP3 |
HGNC: | 1070 |
UniProt: | P12645 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
B-1 B cell | 2.55e-98 | 1 |
mature B cell | 4.52e-50 | 2 |
pre-B-II cell | 4.52e-50 | 2 |
transitional stage B cell | 4.52e-50 | 2 |
small pre-B-II cell | 4.52e-50 | 2 |
immature B cell | 4.52e-50 | 2 |
precursor B cell | 5.96e-34 | 3 |
lymphocyte of B lineage | 1.03e-17 | 24 |
pro-B cell | 1.03e-17 | 24 |
lymphoid lineage restricted progenitor cell | 6.99e-09 | 52 |
lymphocyte | 9.74e-09 | 53 |
common lymphoid progenitor | 9.74e-09 | 53 |
B cell | 2.00e-08 | 14 |
Ontology term | p-value | n |
---|---|---|
lymphatic system cancer | 2.55e-98 | 1 |
lymphosarcoma | 2.55e-98 | 1 |
lymphoma | 2.00e-40 | 10 |
hematologic cancer | 4.95e-09 | 51 |
immune system cancer | 4.95e-09 | 51 |